Physician profile
Larry Chee Chan
NPI 1215259221
$27,585.64
in general payments reported to CMS, 2019-2025
40 companies · $4,654 in 2025
The $4,654 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,286 · 2020: $3,420 · 2021: $1,527 · 2022: $3,462 · 2023: $3,650 · 2024: $6,585 · 2025: $4,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Entertainment: $15.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,874.62 |
| Entertainment | $15.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $6,767.96 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $5,630.25 | 2019-2025 | Avvigo Guidance System, General - Therapies, Emerge Push |
| Edwards Lifesciences Corporation | $3,651.09 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $2,025.04 | 2019-2025 | Amplatzer Talisman, Mitraclip, Amplatzer Amulet |
| Abiomed | $1,568.39 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,436.25 | 2019-2025 | Lifevest |
| Medtronic, INC. | $1,135.17 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Medtronic Vascular, INC. | $854.33 | 2019-2020 | |
| Cardiovascular Systems INC. | $721.73 | 2019-2022 | |
| Acist Medical Systems, INC. | $590.13 | 2019-2021 | |
| Teleflex LLC | $411.57 | 2021-2024 | Guideliner |
| Novartis Pharmaceuticals Corporation | $339.41 | 2019-2024 | |
| Pfizer INC. | $230.75 | 2019-2025 | |
| Biotronik INC. | $226.10 | 2019 | |
| Acutus Medical, INC. | $210.29 | 2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.